electroCore, Inc. (ECOR): Price and Financial Metrics


electroCore, Inc. (ECOR)

Today's Latest Price: $1.62 USD

0.01 (0.58%)

Updated Sep 28 2:17pm

Add ECOR to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 233 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

ECOR Stock Summary

  • ECOR's went public 2.27 years ago, making it older than just 5.42% of listed US stocks we're tracking.
  • ECOR's price/sales ratio is 25.2; that's higher than the P/S ratio of 93.83% of US stocks.
  • As for revenue growth, note that ECOR's revenue has grown 83.42% over the past 12 months; that beats the revenue growth of 93.7% of US companies in our set.
  • Stocks that are quantitatively similar to ECOR, based on their financial statements, market capitalization, and price volatility, are REFR, EB, VCYT, IMMR, and QTRX.
  • Visit ECOR's SEC page to see the company's official filings. To visit the company's web site, go to www.electrocore.com.
ECOR Daily Price Range
ECOR 52-Week Price Range

ECOR Stock Price Chart Technical Analysis Charts


ECOR Price/Volume Stats

Current price $1.62 52-week high $3.30
Prev. close $1.61 52-week low $0.32
Day low $1.60 Volume 274,774
Day high $1.70 Avg. volume 2,672,191
50-day MA $1.80 Dividend yield N/A
200-day MA $1.22 Market Cap 72.10M

electroCore, Inc. (ECOR) Company Bio


electroCore, LLC, a bioelectronic medicine company, engages in developing a range of patient-administered non-invasive vagus nerve stimulation therapies for the treatment of various conditions in neurology, rheumatology, and other fields. It is developing gammaCore, a prescription-only vagus nerve stimulation therapy, for the acute treatment of pain associated with migraine and episodic cluster headache in adults. The company was founded in 2005 and is based in Basking Ridge, New Jersey.


ECOR Latest News Stream


Event/Time News Detail
Loading, please wait...

ECOR Latest Social Stream


Loading social stream, please wait...

View Full ECOR Social Stream

Latest ECOR News From Around the Web

Below are the latest news stories about electroCore Inc that investors may wish to consider to help them evaluate ECOR as an investment opportunity.

Why ElectroCore's Stock Trader Higher Today

ElectroCore (NASDAQ: ECOR) shares are trading higher on Thursday after the company announced an agreement with UpScript to be the exclusive online telehealth provider for gammaCore Sapphire.ElectroCore is a commercial-stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology.The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients.ElectroCore shares were trading up 1.92% at ...

Yahoo | September 24, 2020

electroCore Announces Agreement with UpScript, LLC to be Exclusive Online Telehealth Provider for gammaCore Sapphire™ CV

Comprehensive telehealth platform to facilitate the efficient procurement of gammaCore Sapphire™ CV (non-invasive vagus nerve stimulator) by known or suspected COVID-19 patientsBASKING RIDGE, N.J., Sept. 24, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it has entered into exclusive agreement with UpScript, LLC in which UpScript will serve as the exclusive online telehealth provider for gammaCore Sapphire™ CV (nVNS). Patients can access telehealth consults for the gammaCore Sapphire™ CV product effective immediately by visiting gammaCore.com or directly through getgammaCore.com. “The execution of this agreement with UpScript achieves our goal of establishing an efficient procurement process for certain...

Yahoo | September 24, 2020

electroCore to Participate in the JMP Securities MedTech Bio Summit

BASKING RIDGE, N.J., Sept. 23, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Dan Goldberger, chief executive officer, will participate in a fireside chat at the JMP Securities MedTech Bio Summit, which is being held virtually October 1-2, 2020. Event details:Date: Thursday, October 1, 2020 Time: 2:00pm ETAudio from the event will be webcast live and available here or on the Investors section of the company’s website.About electroCore, Inc.electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The company’s curr...

Yahoo | September 23, 2020

electroCore to Present at the HC Wainwright Virtual 22nd Annual Global Investment Conference

BASKING RIDGE, N.J., Sept. 11, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that management is scheduled to present at the HC Wainwright Virtual 22nd Annual Global Investment Conference, which is being held from September 14-16, 2020. Presentation details: Date: Wednesday, September 16, 2020 Time: 1:30-1:50pm EDTA live webcast of the presentation will be available on the Investors section of the company's website: www.electrocore.comAbout electroCore, Inc.electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. T...

Yahoo | September 11, 2020

LD Micro -- 360 Companies Set to Present this Week

LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.

Yahoo | August 31, 2020

Read More 'ECOR' Stories Here

ECOR Price Returns

1-mo -7.43%
3-mo 97.03%
6-mo 110.39%
1-year -25.52%
3-year N/A
5-year N/A
YTD 1.89%
2019 -74.60%
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7217 seconds.